Australia's most trusted
source of pharma news
Saturday, 14 June 2025
Saturday, 14 June 2025
Subscribe
Login
News Headlines
News Headlines
News
$67M Roche drug under threat
Posted 10 June 2025 AM
Celltrion Healthcare has become the first company to register a biosimilar of Roche’s IL-6 inhibitor Actemra under the brand name Avtozma.
In the year to April, Actemra earned Roche $67,883,044 million in pre-rebate PBS benefits treating certain patients with rheumatoid arthritis, idiopathic arthritis, and active giant cell arteritis.
To see the whole article, please login
Posted 10 June 2025 AM
Celltrion Healthcare has become the first company to register a biosimilar of Roche’s IL-6 inhibitor Actemra under the brand name Avtozma.
In the year to April, Actemra earned Roche $67,883,044 million in pre-rebate PBS benefits treating certain patients with rheumatoid arthritis, idiopathic arthritis, and active giant cell arteritis.
To see the whole article, please login
Popular
Latest Jobs
Pharma in Focus Jobs
Marketing & Communications (3)
- Senior Product Manager - Sydney
- Operations/Production Planner - Parkville
- Data Analyst - Clinical Trials - Kensington
Sales & Customer Relations (15)
- GP Sales Representative - Cairns City
- Customer Service Representative - Sydney
- Customer Care Representative - Macquarie Park
- Medical Representative - Melbourne
- Customer Service Team Leader - East Ryde
- Customer Service Representative - Belrose
- Senior Customer Service Administrator - Belrose
- State Account Manager - Perth
- Medical Representative - Melbourne
- Hospital Specialist Representative - Sunshine Coast
- Hospital Specialist Representative - Brisbane
- Pharmacy Sales Representative - Queensland
- Customer Service Representative - Belrose
- Medical Devices Territory Manager - Brisbane
- Pharmaceutical Sales Representative - Sydney
Clinical & Medical, R&D (13)
- Medical Advisor - Sydney
- Medical Affairs Associate - North Sydney
- Medical Loan Kit Coordinator - Fortitude Valley
- Medical Representative - Melbourne
- Medical Science Liaison - Cardiometabolic (12-month Contract) - Melbourne
- Medical Science Liaison - Victoria
- Quality Control Analytical Technology Scientist - Broadmeadows
- Clinical Trials Pharmacy Manager - Melbourne
- Senior Scientist - Diagnostics - Clayton
- Clinical Trial Investigator - Camberwell
- Medical Representative - Melbourne
- Data Analyst - Clinical Trials - Kensington
- Medical Devices Territory Manager - Brisbane
Regulatory, Pharmacovigilance & QA (3)
- Quality and Training Manager - Ryde
- Quality Control Analytical Technology Scientist - Broadmeadows
- Regulatory Affairs Associate - Lane Cove NSW
Devices (1)
Other (16)
- Omni-channel Specialist - Sydney
- Patient Service Officer - Sydney
- Warehouse Assistant - North Ryde
- Senior Recruitment Consultant - Sydney
- Director of Cloud Engineering - Brisbane
- Category Specialist - North Ryde
- Talent Acquisition Coordinator - Macquarie Park
- People and Culture Coordinator - Macquarie Park
- Inventory Controller - Belrose
- Category Manager - Direct s - North Ryde
- Digital Marketer - Sydney
- GP Rep Brisbane North - Brisbane
- Business Analyst - St Leonards
- ERP Business Partner - Macquarie Park
- Logistics & Warehouse Coordinator - Alexandria
- Service Coordinator - Belrose
MORE NEWS
Email this article to a friend
From:
Print this article
Copyright Notice
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.